CTI-2 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Breast Cancer Cells by Modulating MAPK Signaling Pathway

Although some breast cancer patients die due to tumor metastasis rather than from the primary tumor, the molecular mechanism of metastasis remains unclear. Therefore, it is necessary to inhibit breast cancer metastasis during cancer treatment. In this case, after designing and synthesizing CTI-2, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Junfeng, Han, Wenzhao, Meng, Fanwei, Guo, Feng, Wang, Yuhong, Wang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622910/
https://www.ncbi.nlm.nih.gov/pubmed/34830111
http://dx.doi.org/10.3390/ijms222212229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622910/
https://www.ncbi.nlm.nih.gov/pubmed/34830111
http://dx.doi.org/10.3390/ijms222212229

Ejemplares similares